According to a new report, published by KBV research, The Global Interventional Cardiology Devices Market size is expected to reach $21.9 billion by 2030, rising at a market growth of 7.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 62,100.5 thousand units experiencing a growth of 7.3% (2019-2022).
The Hospitals & Clinics segment is leading the Market by End-use in 2022; thereby, achieving a market value of $16.4 billion by 2030. The use of interventional cardiology devices in hospitals and clinics offers a wide range of benefits, both for healthcare providers and patients. These devices have revolutionized the treatment and management of cardiovascular conditions, improving patient outcomes and healthcare delivery. The reduction in hospitalization and recovery times offered by interventional cardiology devices often leads to overall cost savings in the long term.
The Coronary Stents segment is experiencing a CAGR of 6.9 % during the forecast period. Coronary stents are primarily used to restore blood flow to the heart muscle in cases of coronary artery disease. They can effectively open narrowed or blocked arteries, allowing blood to flow freely. This restoration of blood flow is crucial for preventing heart attacks and alleviating symptoms like angina (chest pain). One of the key benefits of coronary stents is their role in preventing heart attacks. When a coronary artery is blocked, it can lead to a myocardial infarction (heart attack). Stents can prevent this by keeping the artery open and maintaining blood flow.
The North America region dominated the Global Interventional Cardiology Devices Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $7.8 billion by 2030. The Europe region is registering a CAGR of 7% during (2023 - 2030). Additionally, The Asia Pacific region would experience a CAGR of 8.1% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/interventional-cardiology-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, B. Braun Melsungen AG, Biotronik SE & Co. KG , Cardinal Health, Inc. , Teleflex, Inc. , Koninklijke Philips N.V. , and Alvimedica.
By End Use (Volume, Thousand Units, USD Million, 2019-2030)
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings 
